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I 
n this issue of the Journal, Casciola-Rosen et al. (1) call 
. attention to a topic that has been of recent interest, the 
possible association of apoptosis with autoimmunity. Apop- 
tosis, sometimes called programmed cell death, was described 
by Kerr et al. (2)and Wyllie et al. (3) as a form of cell death 
characterized by cell shrinkage, nuclear condensation, and sur- 
face blebbing not accompanied by inflammatory cell infiltra- 
tion. In tissues, it affects scattered single cells rather than tracts 
of contiguous cells, and fragments of apoptotic cells are phago- 
cytosed and digested by resident cells; in epithelial tissue, they 
are taken up by adjacent epithelial cells. A generally accepted 
biochemical correlate of apoptosis is the cleavage of chromatin 
at the intemucleosomal linker regions to produce nucleosomal 
fragments of different lengths which, in agarose gel dectropho- 
resis, appear as DNA ladders (4). In systemic lupus erythema- 
tosus (lupus), which is often regarded as a prototypic systemic 
autoimmune disease, there is a characteristic  autoantibody 
response  directed  against  selected  intracellular  antigens. 
Casciola-Rosen et al. show that UV irradiation of cultured 
human keratinocytes induces changes consistent with apop- 
tosis  and that certain clusters  of appropriate antigens are 
grouped together in different apoptotic blebs in these damaged 
cells. 
The skin has long been recognized as an organ that plays 
an important role in lupus. This is related  to the fact that 
skin rashes are a dominant feature of lupus. Characteristic 
deposits of immunoglobulin and complement at the dermal- 
epidermal junction imply the participation of antibodies in 
its pathogenesis (5). In addition, the disease can manifest clin- 
ically de novo after extended exposure to sunlight and on- 
going disease might be exacerbated after such exposure. For 
these reasons,  the skin and keratinocytes have been objects 
of investigation by several groups (6-8). The novelty of the 
Casciola-Rosen study is the recognition of UV-induced in- 
jury to keratinocytes as consistent with apoptosis and the 
identification of clusters of nuclear and cytoplasmic antigens 
in different translocated sites. A population of smaller apop- 
totic blebs contained fragmented endoplasmic reticulum, ribo- 
somes, and a class of ribonucleoproteins called SS-A/Ro, and 
larger apoptotic blebs contained nucleosomal DNA in addi- 
tion to ribonucleoproteins. 
The prevailing dogma as to how the human organism pro- 
tects itself from autoimmune reactions comes primarily from 
studies in the mouse showing that immature self-reactive T 
cells are deleted or become anergic in the thymus when con- 
fronted with self-antigens on thymic presenting cells, induding 
bone marrow-derived dendritic cells, a process that has been 
called negative selection (9, 10, 11). It appears that one mech- 
anism by which this type of clonal T cell deletion takes place 
is apoptosis (12, 13). The possible rdevance of these observa- 
tions to autoimmunity was heightened by the report that 
the MRL/Mp-Ipr/Ipr mouse, which develops a disease analo- 
gous to human lupus, has an abnormality in the Fas gene 
that mediates apoptosis (14). This abnormality has been de- 
termined to result from integration of the retrotransposon, 
Etn, into the second intron of the Fas gene resulting in di- 
minished Fas expression  and presumably leading to dimin- 
ished or absent Fas-mediated apoptosis (15-17). However, sev- 
eral investigators have reported that Ipr mice do have the 
potential to delete autoreactive T cells (18-20).  It has been 
suggested that in spite of the Fas gene abnormality observed, 
there is the possibility that low levels of Fas protein might 
be expressed (15, 17). At present, the importance of the Fas 
gene in autoimmune murine lupus appears to be unresolved. 
If it does have a role, it is not a universal feature since abnor- 
malities of Fas mRNA expression have not been detected in 
NZB/W thymus or spleen (17), another murine modal of 
lupus which is perhaps closer in clinical and serological fea- 
tures to human lupus than the Igr model. Furthermore, the 
MRL/Mp-+/+  mouse, which is  genetically identical to 
MRL/Ipr except for the lpr abnormality, also develops lupus, 
although later in life. 
A striking feature that has emerged from studies to learn 
more about the structure and function of intranuclear au- 
toantigens is that many of these antigens are involved in im- 
portant or key biosynthetic functions. Some of these are shown 
in Table 1. In diseases like lupus, mixed connective tissue dis- 
ease, scleroderma, and dermatomyositis, autoantigens are in- 
volved in fundamental cell functions such as transcription, 
precursor messenger KNA splicing,  DNA replication, cell 
division, and ribosomal protein synthesis (for a review see 
reference 21). Why cellular components participating in these 
important biosynthetic functions are targeted for autoimmune 
reactions is entirely unclear at the present time. The major 
autoantigens in these diseases have now been identified (21), 
and it appears that there might be a preferential  autoanti- 
body response to biosynthetic nuclear and cytoplasmic com- 
ponents and a paucity of antibody responses to structural and 
membrane components. 
Many investigators have been interested in defining the an- 
tigenic determinants or epitopes that are recognized by au- 
toantibodies. An emerging consensus from these studies is 
that many autoepitopes are not continuous primary sequence 
peptides but are conformation dependent and made up of 
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Disease  Identity and structure  of antigen  Function  of antigen 
Lupus  Sm -common proteins  of small  Splicing of precursor 
nuclear ribonucleoprotein particles  messenger RNA 
(snKNP),  U1,U2,U4-U6 snRNPs 
PCNA-Auxiliary  protein  of DNA 
polymerase delta 
U1 sngNP-specific proteins of U1 
RNP particle 
Lupus 
Lupus and mixed 
connective tissue 
disease 
Lupus and scleroderma 
Scleroderma 
Scleroderma (CREST*) 
Dermatomyositis 
NOR-90-Nucleolus  organizer 
region proteins 
Scl-70-DNA topoisomerase I 
Centromere-associated proteins of 
17,80, and 140 kD 
Transfer RNA (tKNA  his'thr'~l~) 
synthetases 
DNA replication-leading 
strand synthesis 
Splicing of pre-mRNA 
RNA pol I transcription 
Relaxation of supercoiled 
DNA 
Spindle attachment in cell 
mitosis 
Ribosomal protein  synthesis 
* CREST is the acronym  for a subset of scleroderma  characterized  by Calcinosis, Raynaud's phenomenon,  Esophageal dysmotility, Sclerodactyly, 
and Telangiectasia. 
discontinuous sequences either as a result of protein folding 
or of protein-protein interactions (22-25).  A case in point 
involved studies on proliferating cell nuclear antigen (PCNA) 
where it was shown that lupus autoantibodies were totally 
nonreactive with continuous sequence peptides of PCNA in 
contrast to experimentally induced routine monoclonal anti- 
bodies which reacted strongly with these peptides (26). The 
significance of the observation that human autoantibodies fre- 
quently recognize only conformation-dependent peptides was 
reinforced by the findings that human autoantibodies were 
capable  of inhibiting the known functions of autoantigens 
such as splicing by snKNP particles, DNA replication (by 
PCNA), and ribosomal protein synthesis (by tKNA synthe- 
tases).  In the case of PCNA and tRNA thr synthetase, ex- 
perimental monoclonal antibodies recognizing continuous se- 
quences were ineffective (27, 28). The cumulative data strongly 
suggest that many autoepitopes involve the active sites or func- 
tional domains of these intracellular particles and it might 
be expected that these regions would be evolutionarily con- 
served. This notion is already implicit in routine testing when 
detection of autoantibodies to nuclear and cytoplasmic an- 
tigens can be ascertained in immunofluorescence, using tissue 
or cell culture substrates ranging widely across species from 
mammalian to  avian,  amphibian,  and sometimes to plant 
kingdoms. The highly conserved nature of epitopes recog- 
nized by autoantibodies is illustrated in a study depicted in 
Table 2 where reactivity of a human aut0antibody to SS-B/La, 
a nuclear protein of 48 kD involved in KNA polymerase III 
transcript maturation, is compared with reactivity of several 
experimentally induced murine monodonal  antibodies  to 
purified bovine antigen (29).  Murine antibodies were non- 
reactive with antigen in species more closely related to itself 
whereas human antibody was pan-reactive. 
The central question that has always arisen is why autoan- 
tibodies are mounted against ubiquitous self-antigens that 
are functionally important. Perhaps some clues to this issue 
are coming from studies on p53,  a tumor suppressor gene 
that has been called the 1993 molecule of the year (30). The 
p53 molecule has a role in transcription and in cell cycle con- 
trol so that in these properties it is much like lupus and other 
autoimmune antigens. About 10%  of patients with breast 
cancer have circulating antibodies to p53 protein (31). In these 
patients, there were missense mutations in exons 5 and 6 of 
the gene resulting in p53 overexpression, whereas no anti- 
bodies were detected in patients with low level p53 expres- 
sion. Moreover, tumors in patients with antibodies contained 
complexes between p53 and a 70-kD heat shock protein. It 
was suggested that the 70-kD protein might be involved in 
antigenic presentation of p53.  It was also noteworthy that 
antibodies reacted with wild type p53 as well as mutant p53 
proteins. Antibodies to p53 have also been detected in about 
13%  of patients with lung cancer, and it was also shown 
that these patients also had missense mutations in certain exons 
(32).  In view of these findings, it would be of interest to 
1084  Commentary Table  2.  Comparison of SS-B/La Epitopes Recognized by Human Autoantibody and Experimentally Induced Antibodies 
Immunofluorescence  * 
Murine  mABs 
Species  Cell line  A1  A2  A3 
Human serum 
Ze 
Human  Hep-2, larynx  +  +  + 
Human  HeLa, cervix  +  +  + 
Human  Raji,  Burkitt,  lymphoma  +  +  + 
Monkey  Vero,  kidney  +  +  + 
Rabbit  R9ab,  lung  +  +  + 
Bovine  MDBK,  kidney  +  +  + 
Hamster  BHK-21,  kidney  -  -  - 
Rat  6m2,  kidney  -  -  - 
Mouse  3T3  fibroblast  -  -  - 
Rat kangaroo  PtK2,  kidney  -  -  - 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
* Immunofluorescence performed on cell lines to detect nuclear fluorescence of anti-SS-B/La specificity (29). 
determine whether these abnormalities might be present in 
lupus  and  other  systemic autoimmune  diseases. 
Many questions  remain to be explored in order to eluci- 
date mechanisms related to human autoimmune diseases, and 
the stage may be set for significant  advances since some of 
the current  knowledge  summarized above points to certain 
directions of investigation.  The work of Casciola-Rosen et 
al. suggests that apoptosis might be a mechanism inducing 
the clustering  of potentially immunogenic cellular compo- 
nents,  a process which  might  explain why  antibodies  in  a 
particular disease are directed at multiple antigens. The out- 
come of further studies to test this notion would clearly be 
of interest. 
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